clarithromycin has been researched along with Airflow Obstruction, Chronic in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 19 (55.88) | 29.6817 |
| 2010's | 11 (32.35) | 24.3611 |
| 2020's | 4 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Kriengwattanakul, O; Kulalert, P; Morasert, T | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
| Begbey, A; Guppy, JH; Mohan, C; Webster, S | 1 |
| Chen, Y; Lin, A; Luo, G; Mo, C; Yang, Z | 1 |
| Vora, A | 1 |
| Herath, SC; Maisey, S; Normansell, R; Poole, P | 1 |
| Akram, A; Chalmers, JD; Hill, AT; Schembri, S; Short, PM; Singanayagam, A; Taylor, J; Williamson, PA | 1 |
| Donaldson, GC; James, GD; Nazareth, I; Petersen, I; Wedzicha, JA | 1 |
| Herath, SC; Poole, P | 1 |
| Colombo, G; Haghi, M; King, G; Saadat, A; Traini, D; Young, PM; Zhu, B | 1 |
| Hofmann, T; Scheuch, G; Siekmeier, R | 1 |
| Yamaya, M | 1 |
| Fernandes, SE; Laurenson, IF; Noble, DD; Velu, PP | 1 |
| Baconnet, B; Léophonte, P; Perronne, C; Zuck, P | 1 |
| Barber, C; Horton, R | 1 |
| Fukuchi, Y; Ichinose, M; Kudo, S; Seemungal, TA; Yamatani, M | 1 |
| Anić-Milić, T; Bogdan, M; Bosnar, M; Culić, O; Eraković Haber, V; Marjanović, N; Michielin, F; Parnham, MJ; Popović-Grle, S; Willé, DR | 1 |
| Decramer, M; Laekeman, G; Simoens, S | 1 |
| Malcolm, C; Marrie, TJ | 1 |
| Gotfried, MH | 1 |
| Banerjee, D; Honeybourne, D; Khair, OA | 2 |
| Basyigit, I; Boyaci, H; Ilgazli, A; Ozkara, SK; Yildirim, E; Yildiz, F | 1 |
| Miravitlles, M; Torres, A | 1 |
| Eller, J; Ioanas, M; Linnhoff, A; Lode, H | 1 |
| Cots, JM; Llor, C; Miravitlles, M; Molina, J; Naberan, K | 2 |
| Carricajo, A; Fournel, P; Job, V; Lacaze, O; Vergnon, JM | 1 |
| Andreu Rodríguez, AL; Bertomeu Martínez, V; Díaz García, MJ; Morillas Blasco, P | 1 |
| Aliredjo, RP; Cox, AL; Dekhuijzen, PN; Majoor, CJ | 1 |
| Ergeshev, AE; Shmelev, EI; Shmeleva, NM; Sidorova, VP | 1 |
| Falguera, M; Giménez, A; Gómez-Arbonés, X; Porcel, JM; Ruiz-González, A; Sánchez, V; Soler-González, J | 1 |
| Bailly-Botuha, C; Bellon, G; de Blic, J; Galmiche, L; Jaubert, F; Picard, C; Taam, RA | 1 |
8 review(s) available for clarithromycin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Role of Clarithromycin in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Topics: Anti-Bacterial Agents; Clarithromycin; Humans; Pulmonary Disease, Chronic Obstructive | 2017 |
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Disease Progression; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Roxithromycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Disease Progression; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic | 2013 |
Inhalation of macrolides: a novel approach to treatment of pulmonary infections.
Topics: Administration, Inhalation; Aerosols; Animals; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; Cystic Fibrosis; Erythromycin; Humans; Ketolides; Lung; Macrolides; Pulmonary Disease, Chronic Obstructive; Rats | 2015 |
[Effects of mucolytic agents and macrolides in the treatment of COPD].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antiviral Agents; Clarithromycin; Disease Progression; Drug Therapy, Combination; Erythromycin; Expectorants; Goblet Cells; Humans; Hyperplasia; Macrolides; Mucins; Mucociliary Clearance; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Retrospective Studies; Treatment Outcome | 2016 |
Preventing COPD exacerbations with macrolides: a review and budget impact analysis.
Topics: Anti-Bacterial Agents; Azithromycin; Belgium; Clarithromycin; Drug Costs; Erythromycin; Health Care Costs; Humans; Macrolides; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2013 |
Macrolides for the treatment of chronic sinusitis, asthma, and COPD.
Topics: Anti-Bacterial Agents; Asthma; Chronic Disease; Clarithromycin; Clinical Trials as Topic; Humans; Immunologic Factors; Pulmonary Disease, Chronic Obstructive; Sinusitis | 2004 |
8 trial(s) available for clarithromycin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
The effect of oral clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomized controlled trial.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Bronchi; Clarithromycin; Cytokines; Delayed-Action Preparations; Double-Blind Method; Female; Follow-Up Studies; Humans; Leukocyte Count; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index | 2004 |
The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Biomarkers; Clarithromycin; Double-Blind Method; Humans; Inflammation Mediators; Interleukin-8; Leukotriene B4; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Sputum; Tumor Necrosis Factor-alpha | 2004 |
Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Progression; Double-Blind Method; Female; Germany; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Statistics, Nonparametric; Treatment Outcome | 2004 |
The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Female; Forced Expiratory Volume; Health Status; Humans; Male; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Smoking; Sputum; Treatment Outcome; Vital Capacity | 2005 |
Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Topics: Acute Disease; Adrenergic beta-Agonists; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clarithromycin; Drug Therapy, Combination; Epidemiologic Methods; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Oxygen Inhalation Therapy; Prognosis; Pulmonary Disease, Chronic Obstructive; Quinolines; Treatment Outcome | 2005 |
[Clarythromycin in the treatment of exacerbations of chronic obstructive lung disease].
Topics: Anti-Bacterial Agents; Clarithromycin; Disease Progression; Female; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index | 2006 |
Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
Topics: Amoxicillin; Anti-Infective Agents; Cefuroxime; Clarithromycin; Female; Follow-Up Studies; Forced Expiratory Volume; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Oximetry; Pulmonary Disease, Chronic Obstructive; Quality of Life; Recurrence; Survival Rate; Time Factors; Treatment Outcome | 2007 |
19 other study(ies) available for clarithromycin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Effect of Macrolide Antibiotics on In-Hospital Mortality Among Acute Exacerbation of COPD Patients: A Propensity Score-Matched Analysis.
Topics: Anti-Bacterial Agents; Clarithromycin; Hospital Mortality; Humans; Macrolides; Propensity Score; Pulmonary Disease, Chronic Obstructive; Retrospective Studies | 2022 |
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Comorbidity; Crohn Disease; Enterobacteriaceae Infections; Female; Hafnia alvei; Humans; Immunocompromised Host; Male; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Rare Diseases; Treatment Outcome; Young Adult | 2020 |
Computerized Tomography Image Feature under Convolutional Neural Network Algorithm Evaluated for Therapeutic Effect of Clarithromycin Combined with Salmeterol/Fluticasone on Chronic Obstructive Pulmonary Disease.
Topics: Bronchodilator Agents; Clarithromycin; Fluticasone-Salmeterol Drug Combination; Humans; Neural Networks, Computer; Pulmonary Disease, Chronic Obstructive; Tomography, X-Ray Computed | 2021 |
Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies.
Topics: Acute Coronary Syndrome; Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Disease Progression; Female; Follow-Up Studies; Guideline Adherence; Hospitalization; Humans; Male; Middle Aged; Pneumonia; Proportional Hazards Models; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk Factors; United Kingdom | 2013 |
Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cohort Studies; Disease Progression; Doxycycline; Erythromycin; Female; Humans; Longitudinal Studies; Male; Middle Aged; Oxytetracycline; Penicillins; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Sex Factors; United Kingdom | 2013 |
The formulation, chemical and physical characterisation of clarithromycin-based macrolide solution pressurised metered dose inhaler.
Topics: Administration, Inhalation; Aerosol Propellants; Aerosols; Chemistry, Pharmaceutical; Clarithromycin; Drug Delivery Systems; Drug Stability; Macrolides; Metered Dose Inhalers; Particle Size; Pneumonia; Pulmonary Disease, Chronic Obstructive; Solutions | 2014 |
Pulmonary Mycobacterium marinum infection: 'fish tank granuloma' of the lung.
Topics: Aged; Animals; Antibiotics, Antitubercular; Clarithromycin; Cough; Ethambutol; Fishes; Humans; Lethargy; Male; Mycobacterium Infections, Nontuberculous; Pulmonary Disease, Chronic Obstructive; Rifampin; Treatment Outcome; Wastewater; Weight Loss | 2016 |
[Routine use of extended-release clarithromycin tablets for short-course treatment of acute exacerbations of non-severe COPD].
Topics: Administration, Oral; Adult; Aged; Bacterial Infections; Child; Clarithromycin; Delayed-Action Preparations; Disease Progression; Drug Tolerance; Female; France; Humans; Middle Aged; Physicians, Family; Pulmonary Disease, Chronic Obstructive; Rural Population; Smoking; Urban Population | 2008 |
Opioid-induced respiratory depression resulting from transdermal fentanyl-clarithromycin drug interaction in a patient with advanced COPD.
Topics: Administration, Cutaneous; Aged, 80 and over; Analgesics, Opioid; Anti-Bacterial Agents; Clarithromycin; Dementia; Drug Interactions; Fentanyl; Humans; Male; Neck Pain; Pulmonary Disease, Chronic Obstructive; Respiratory Insufficiency | 2009 |
[Potential role of macrolides in the treatment of COPD: current evidence. (discussion)].
Topics: Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Cytokines; Depression, Chemical; Erythromycin; Humans; Immunologic Factors; Inflammation Mediators; Macrolides; Pulmonary Disease, Chronic Obstructive; Receptors, Virus; Risk Assessment | 2009 |
Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Survival; Cells, Cultured; Chemokines; Clarithromycin; Cytokines; Erythromycin; Humans; Macrolides; Pulmonary Disease, Chronic Obstructive; Roxithromycin; Sputum | 2011 |
[Fluoroquinolone superior to macrolide. Longer infection free period after acute bronchitis].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Bronchitis; Clarithromycin; Double-Blind Method; Follow-Up Studies; Humans; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Recurrence | 2003 |
Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting.
Topics: Adolescent; Adult; Aged; Alberta; Ambulatory Care; Analysis of Variance; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Emergency Service, Hospital; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2003 |
Antibiotics in exacerbations of COPD: lessons from the past.
Topics: Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Progression; Humans; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic | 2004 |
Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clarithromycin; Clavulanic Acid; Cost of Illness; Cost-Benefit Analysis; Data Collection; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Quinolines; Treatment Outcome | 2004 |
[Medical-surgical treatment of pulmonary infection with Mycobacterium malmoense].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Pulmonary Disease, Chronic Obstructive; Tuberculosis, Pulmonary | 2004 |
[EKG changes in a patient with respiratory infection].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Electrocardiography; Humans; Long QT Syndrome; Male; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections | 2005 |
[Diffuse panbronchiolitis in an Asian woman with severely obstructed pulmonary disease].
Topics: Adult; Anti-Bacterial Agents; Asian People; Bronchiolitis; Clarithromycin; Diagnosis, Differential; Female; Humans; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Severity of Illness Index; Treatment Outcome | 2006 |
Diffuse lymphoplasmacytic bronchiolitis in cartilage-hair hypoplasia.
Topics: Abnormalities, Multiple; Biopsy, Needle; Bronchiolitis; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child, Preschool; Chondrodysplasia Punctata; Clarithromycin; Dwarfism; Female; Follow-Up Studies; Hair; Humans; Hypotrichosis; Immunohistochemistry; Lung; Lymphopenia; Male; Plasma Cells; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Respiratory Function Tests; Risk Assessment; Severity of Illness Index; Syndrome; Tomography, X-Ray Computed; Treatment Outcome | 2008 |